{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=aripiprazole+tablets&page=2", "query": { "intervention": "aripiprazole tablets", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=aripiprazole+tablets&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T00:22:32.168Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06372210", "title": "A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mental Disorder", "Schizophrenia", "Major Depressive Disorder", "Bipolar I Disorder" ], "interventions": [ { "name": "Placebo IEM tablet", "type": "DRUG" }, { "name": "Abilify MyCite®", "type": "DRUG" }, { "name": "D-Tect Patch", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2023-06-26", "completion_date": "2023-07-19", "has_results": true, "last_update_posted_date": "2024-07-31", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 1, "location_summary": "Garden Grove, California", "locations": [ { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06372210" }, { "nct_id": "NCT00261443", "title": "A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Lithium or Valproate with placebo (PBO)", "type": "DRUG" }, { "name": "Lithium or Valproate with Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1270, "start_date": "2005-09", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 29, "location_summary": "Tuscaloosa, Alabama • Anaheim, California • Cerritos, California + 24 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00261443" }, { "nct_id": "NCT00097266", "title": "Study of Aripiprazole in Patients With Acute Bipolar Mania", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 615, "start_date": "2004-12", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 15, "location_summary": "Anaheim, California • Cerritos, California • Garden Grove, California + 12 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Pico Rivera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097266" }, { "nct_id": "NCT00101569", "title": "Aripiprazole Oral Acceptability Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2004-03", "completion_date": "2005-03", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 7, "location_summary": "Anaheim, California • National City, California • North Miami Beach, Florida + 4 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Staten Island", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00101569" }, { "nct_id": "NCT02431702", "title": "A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia", "Psychotic Disorders" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Oral Paliperidone ER", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Oral Risperidone", "type": "DRUG" }, { "name": "Paliperidone Palmitate Injection (PP1M)", "type": "DRUG" }, { "name": "Paliperidone Palmitate Injection (PP3M)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 337, "start_date": "2015-07-08", "completion_date": "2019-11-12", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 34, "location_summary": "Little Rock, Arkansas • Garden Grove, California • Lemon Grove, California + 31 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02431702" }, { "nct_id": "NCT00706654", "title": "Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Aripiprazole depot 300 or 400 mg", "type": "DRUG" }, { "name": "Aripiprazole 10-30 mg orally", "type": "DRUG" }, { "name": "Aripiprazole depot 25 or 50 mg", "type": "DRUG" }, { "name": "Placebo depot", "type": "DRUG" }, { "name": "Placebo tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 937, "start_date": "2008-09-01", "completion_date": "2012-08-01", "has_results": true, "last_update_posted_date": "2026-06-04", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 39, "location_summary": "Cerritos, California • Escondido, California • Garden Grove, California + 31 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00706654" }, { "nct_id": "NCT00361790", "title": "Aripiprazole and Lexapro Drug Interaction Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Escitalopram on days -7 to day 14; Aripiprazole dosed starting Day 1 to day 14: 3 days at 10 mg, 4 days at 15 mg and 7 days at 20 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 25, "start_date": "2006-08", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 1, "location_summary": "Lenexa, Kansas", "locations": [ { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00361790" }, { "nct_id": "NCT00592683", "title": "Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pediatric Bipolar Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "fish oil", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 20, "start_date": "2007-12", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2012-04-06", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 1, "location_summary": "Cambridge, Massachusetts", "locations": [ { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00592683" }, { "nct_id": "NCT00953745", "title": "Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Escitalopram", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo Capsule", "type": "DRUG" }, { "name": "Placebo Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 43, "start_date": "2009-05", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2018-04-19", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00953745" }, { "nct_id": "NCT01207414", "title": "Switching to Iloperidone From Other Antipsychotics in Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "iloperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 501, "start_date": "2010-08", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-03-15", "last_synced_at": "2026-09-27T00:22:32.168Z", "location_count": 59, "location_summary": "Birmingham, Alabama • Cerritos, California • Costa Mesa, California + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01207414" } ] }